Gastrointestinal stromal tumors (GISTs) are uncommon cancers that start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract.

Using single-cell RNA sequencing, researchers say they have identified and characterized rare cell types in the gastrointestinal tract.

Human gastrointestinal epithelia of the esophagus, stomach and duodenum resolved at single-cell resolution. Cell Reports , 2021 DOI: 10.1016/j.celrep.2021.108819 Cite This Page : ...

GI Cell announced its research license and option agreement with Optieum Biotechnologies to accelerate the development of CAR-NK products.

One of the biggest advancements in upper GI cancer care is the use of immunotherapy. This type of medicine helps the body's own immune system find and attack cancer cells. Some cancers grow because ...

Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues. Nature Cancer, 2022; DOI: 10.1038/s43018-022-00344-7; ...

The study, published 20 November in Nature, details how the team harmonized over 25 single-cell datasets of the human gastrointestinal (GI) tract to create the world's largest freely-available ...

Viral gastrointestinal infection and potential fecal-oral transmission can last even after viral clearance from the respiratory tract The study looked at 73 patients hospitalized for possible ...

GI CELL, Inc. announced today that it has entered into a research license and option agreement with Optieum Biotechnologies, Inc. (Japan). Under the agreement, Optieum Biotechnologies will provide ...